Larson Financial Group LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1731061 ST LOUIS, MO

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$203,143

+$60,604 QoQ

Shares Held

1,542

+53.4% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Larson Financial Group LLC holds $2,020,512 across 41 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (10.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	6,129	$724,509
2	NBIX	Neurocrine Biosciences Inc This page	1,542	$203,143
3	TAK	Takeda Pharmaceutical Co Ltd	7,759	$143,696
4	HIMS	Hims & Hers Health, Inc.	6,697	$139,029
5	HLN	Haleon plc	12,224	$122,362
6	LNTH	Lantheus Holdings, Inc.	1,453	$110,210
7	UTHR	UNITED THERAPEUTICS Corp	181	$107,329
8	HROW	Harrow, Inc.	2,277	$80,287

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$203,143	1,542	+53.4%	Shares	Sole	2026-05-15
2025-12-31	$142,539	1,005	+32.8%	Shares	Sole	2026-02-06
2025-09-30	$106,267	757	+6.6%	Shares	Sole	2025-11-14
2025-06-30	$89,239	710	+77.5%	Shares	Sole	2025-08-08
2025-03-31	$44,240	400	-71.7%	Shares	Sole	2025-05-02
2024-12-31	$192,874	1,413	+0.9%	Shares	Sole	2025-02-07
2024-09-30	$161,423	1,401	-26.0%	Shares	Sole	2024-11-12
2024-06-30	$260,609	1,893	-14.5%	Shares	Sole	2024-08-02
2024-03-31	$305,216	2,213	-1.9%	Shares	Sole	2024-05-03
2023-12-31	$297,382	2,257	+20418.2%	Shares	Sole	2024-02-01
2023-09-30	$1,237	11	-99.5%	Shares	Sole	2023-11-03
2022-12-31	$278,414	2,331	+20.2%	Shares	Sole	2023-02-03
2022-09-30	$206,047	1,940	+6.7%	Shares	Sole	2022-11-03
2022-06-30	$177,218	1,818	—	Shares	Sole	2022-08-04
No filing history on record for this holder in this stock.